Is pain perception altered in people with depression? A systematic review and meta-analysis of experimental pain research by Thompson, Trevor et al.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
1
 
Is pain perception altered in people with depression? A systematic 
review and meta-analysis of experimental pain research 
Trevor Thompson
a
, PhD, Christoph U. Correll
b
, MD, Katy Gallop
c
, MSc, Davy 
Vancampfort
d,e
, PhD, Brendon Stubbs
f,g
, PhD 
 
 
a
Faculty of Education and Health, University of Greenwich, London SE9 2UG, UK  
b
Zucker Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004, USA 
c
Acaster Consulting, London SE3 7HU, UK 
d
KU leuven, UPC Z.org, Leuvensesteenweg 517, B-3070 Kortenberg, Belgium 
e
KU Leuven Department of Rehabilitation Sciences, Tervuursevest 101, B-3001 Leuven, 
Belgium 
f
Physiotherapy Department, South London and Maudsley NHS Foundation Trust, London SE5 
8AZ, UK 
g
Health Service and Population Research Department, Institute of Psychiatry, Psychology and 
Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK 
 
Corresponding Author:   
Trevor Thompson 
Email: t.thompson@gre.ac.uk 
Telephone: +4420 8331 9632 
 
 
 
Disclosures 
BS, TT and KG have no conflicts of interest. 
Dr. Correll has been a consultant and/or advisor to or has received honoraria from AbbVie, 
Actavis, Alkermes, Bristol-Myers Squibb, Eli Lilly, Genentech, Gerson Lehrman Group, 
IntraCellular Therapies, Janssen/J&J, Lundbeck, MedAvante, Medscape, Otsuka, Pfizer, 
ProPhase, Reviva, Roche, Sunovion, Supernus, and Takeda. He has received grant support 
from Bristol-Myers Squibb, Otsuka, and Takeda.  
Dr Davy Vancampfort is funded by the Research Foundation - Flanders (FWO-Vlaanderen).  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
2
Abstract 
While clinical studies suggest depressed patients may be more vulnerable to pain, 
experimental research is equivocal. This meta-analysis aimed to clarify whether depression 
is associated with altered pain perception in response to noxious stimulation and to identify 
factors that might influence this association. A search of major electronic databases was 
conducted to identify experimental studies investigating pain response in depressed 
participants vs. healthy controls using established pain outcome measures. Random effects 
meta-analysis of standardized mean differences was conducted on data from 32 studies 
(N=1,317). For high-intensity noxious stimulation, overall pain tolerance was similar across 
depressed and control groups (Hedge's g=0.09, p=0.71, studies=10). For low-intensity 
stimulation, a small, but statistically significant higher mean sensory threshold (g=0.35, 
p=0.01, studies=9) and pain threshold (g=0.32, p=0.02, studies=25) was observed in 
depressed participants, suggesting diminished pain. However, considerable heterogeneity in 
the direction and magnitude of effects was observed, indicating a likely condition-specific 
impact of depression on pain. Subgroup analysis found that pain threshold/tolerance was 
increased in depression for exteroceptive (cutaneous) stimulation but decreased for 
interoceptive (ischemic) stimulation, but that substantial heterogeneity remained. Overall, 
results provide some support for altered pain processing in depression, but suggest this link 
is dependent upon modality and additional, unidentified factors. 
Perspective 
This meta-analysis of experimental studies suggests potential effects of depression on pain 
perception are variable and likely to depend upon multiple factors. The contrasting pattern 
for ischemic vs. other noxious stimuli suggests that stimulus modality is a key factor, which 
could help explain discrepancies across clinical and experimental findings.  
Key words: Depression; depressive disorder; pain; meta-analysis; systematic review. 
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Introduction 
Depression and pain are frequently observed as comorbid conditions in clinical settings. 
They represent two of the leading predictors of years lived with disability across the world
73
, 
and appear to interact to prove costlier and more disabling than the sum of their individual 
effects
2
. Patients with depression often present with medically unexplained somatic 
complaints, such as abdominal pain, back pain and headache
35
, with mean pain prevalence 
estimated as 65%
2
 compared to around 29% for non-depressed populations
15
. Moreover, 
the presence of depression may predict future musculoskeletal pain
40
 and is a key risk factor 
for chronic low back pain
53
 suggesting a causal influence. The biochemical theory of 
depression suggests that a neurochemical imbalance of monoamines (e.g. serotonin) 
underlies depression and, given that these neurotransmitters are likely to play a key role in 
modulatory pain pathways, this may lead to altered pain perception
2,27
. Neural mechanisms 
common to depression and pain have also been implicated, with areas of the brain linked to 
mood (e.g. amygdala, insular) also sending numerous projections to key structures involved 
in pain modulation (e.g. periaqueductal gray)
2,22
.  
If pain perception abnormalities are a manifestation of depression, this may have important 
treatment and diagnostic implications. For example, Fishbain et al.
24
 found that the impact 
of antidepressant medication on depression response/remission may be impaired when pain 
is present. Pain may also influence diagnostic accuracy, with failure to accurately diagnose 
major depression by physicians estimated to exceed 50%
31,46
, with presence of painful 
symptoms being central to misdiagnosis
13,32
. One large review found that 69% of individuals 
experiencing depression tended to disclose only somatic symptoms
59
, explaining why 
depression is frequently misdiagnosed as a somatic illness
71
. The consequences of failing to 
recognize depression can be severe, as untreated depression often becomes worse, leading 
to poorer outcomes
55
. 
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Pain perception abnormalities in depression have also been examined using experimental 
paradigms to provide a level of control difficult to achieve in clinical settings, and to facilitate 
the assessment of pain across multiple dimensions, including subjective, behavioral and 
psychophysiological responses. Surprisingly, a preliminary meta-analysis of six experimental 
studies
16
 found decreased pain in depressed groups relative to healthy controls.  Whilst 
informative, a considerable number of studies have been conducted since the publication of 
the original review 13 years ago. Furthermore, limited data availability restricted the review 
to an examination of pain threshold only, which assesses minimal intensity pain
75
, and which 
in isolation is of limited clinical relevance. Since this review, there has been mounting 
interest in depression and pain perception with many experimental studies conducted over 
the past decade, producing equivocal findings. One possible explanation for this equivocality 
is that the link between depression and pain perception may be dependent upon the type of 
noxious stimulus used, with one theory
37
 suggesting that different sources of pain (e.g. 
exteroceptive vs. interoceptive) are subserved by distinct pain inhibitory systems and these 
can be affected differentially by depression. While preliminary evidence appears to supports 
this theory, the influence of stimulus modality as a possible moderator has yet to be subject 
to systematic review. To better understand the link between depression and pain, there is a 
pressing need to provide an updated review and synthesis of the recent experimental pain 
literature, examining potential moderators and more clinically relevant measures, such as 
pain tolerance
75
, pain affect and pain intensity ratings. 
Therefore, we conducted a comprehensive systematic review and meta-analysis comparing 
depressed and healthy control groups in their response to experimentally-induced pain. 
Specific aims were to examine: (1) whether depressed vs. healthy controls differed in 
sensitivity to experimentally-administered noxious stimuli,  (2) whether differences would 
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be confined to specific pain outcomes, and (3) which variables moderated the observed 
effects. 
 
Method 
This systematic review was conducted in accordance with the MOOSE guidelines
64
 and the 
PRISMA statement
47
. 
Eligibility criteria 
Studies were included that utilized: (1) a group with current depression, as defined by a 
primary diagnosis of a depressive disorder based on a clinical instrument (e.g. DSM, ICD) or a 
standardized questionnaire (e.g. the Beck Depression Inventory); (2) a comparative control 
group of healthy, non-depressed individuals; (3) an experimental sensory stimulus; and (4) 
at least one of the following outcome measures: pain threshold, pain tolerance, pain ratings 
or sensory threshold. 
 
Studies were excluded if: (1) depression was a secondary diagnosis, (2) depressed groups 
suffered from a chronic pain condition, (3) classification as depressed was based on 
experimental mood induction, or (4) pain perception was assessed during an experimental 
manipulation of mood or attention. 
 
Information sources and search details 
Two independent reviewers (KG, TT) searched EMBASE, MEDLINE, PsycINFO and the Web of 
Science from database inception until 7
th
 April, 2015.  Our search used a widely inclusive 
strategy, identifying articles that contained appropriate combinations of broad and specific 
keywords relating to eligibility criteria; precise search term combinations are reported in 
Table S1 along with number of hits returned for the Medline database as an exemplar. Due 
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to the large number of results, studies reporting randomized clinical trials were excluded 
and the search results were refined using limits of human studies and English language. 
Additional studies were identified from reference lists of relevant articles. 
 
Study selection 
After removal of duplicates, two reviewers (KG, TT) screened titles and abstracts for 
eligibility, and developed a list of full text articles through consensus. Two authors (TT, BS) 
considered the full texts of included articles and a final list of eligible articles was agreed. We 
contacted authors up to 3 times over a month to clarify study eligibility and/or acquire 
additional data. 
 
Outcomes 
Multiple primary outcomes were used to capture different aspects of pain response
25
: (1) 
pain threshold (the point at which pain is first perceived), (2) pain tolerance (the point at 
which pain can no longer be tolerated), and (3) self-reported ratings of pain intensity/affect. 
Sensory threshold (the point at which sensation is first perceived) was  included as a 
secondary outcome to investigate whether differences in pain perception were 
accompanied by differences in non-painful sensory perception.  
 
Data Extraction 
Study data were extracted independently by two authors (TT, KG) using a standardized 
extraction form that we have used in several of our previous studies
65,66
 but with a few, 
relatively minor adaptations for the topic of depression and pain perception, so coding 
protocols were very clear and unambiguous. Details were recorded for pain induction 
method, pain assessment outcome, depressed group (demographics, diagnostic method, 
symptom severity, antidepressant medication), control group (demographics), study design 
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and geographical location. We recorded group means and standard deviations for each pain 
outcome measure, or any other available information that would allow computation of 
effect size (see 'Meta-Analysis' section below). To minimize reporting bias, authors were also 
contacted for statistical details when non-significant findings were reported but in 
insufficient detail to allow computation of effect sizes. 
 
When a study reported pain outcome data at different time points, we extracted averaged 
data if available, otherwise we extracted data at the first time point.  When outcome data 
were collected at multiple stimulus intensities (usually applicable to electrical stimulation), 
the highest intensity was extracted as this was most likely to reliably evoke pain. When  
a study applied noxious stimulation to both left and right sides of the body, we used pain 
scores averaged across sites where possible, otherwise we extracted data from the right side 
as this was the most common site tested and may show greater sensitivity to detecting 
differences in pain response and increased homogeneity in our analyses
4
. From studies 
reporting pain data in participants before and after antidepressant treatment, we used 
unmedicated data for the overall pooled analyses, but we used data from treated patients 
for the medicated/unmedicated subgroup analysis. Finally, a few studies used sensory 
decision theory to yield two measures of pain threshold: response criterion and d-prime 
(sensory discrimination). Response criterion was abstracted as the data of interest, as this 
measure is the most closely related to verbally declared pain threshold used in the other 
included studies
25
. 
 
Methodological study appraisal 
Two authors (TT, BS) independently completed methodological quality assessment of 
included articles using the case-control Newcastle Ottawa Scale
74
 (NOS).  If any 
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disagreement arose, a third author (CC) was available for mediation. The NOS provides an 
assessment of the methodological quality of non-randomized trials and its content validity 
and reliability have been established.  Included studies are judged on 9 items across three 
key areas: selection of the participants, comparability of the participants, and outcomes.  
Each study receives an overall score for methodological quality of up to 9 points (one for 
each item) and scores of 5 and above are considered to reflect satisfactory study quality
74
. 
 
Meta- analysis 
As we anticipated heterogeneity in effect sizes due to variation in important study 
characteristics typical in experimental pain research, a random effects model using the 
method of moments was chosen. This allows heterogeneity to be accounted for statistically 
and permits generalization to studies beyond those examined in the meta-analysis. Hedges’s 
g was calculated as the effect size based on standardized differences in pain scores between 
participants with depression and controls. All analysis was performed using Comprehensive 
Meta-Analysis software (CMA, version 3). When computing Hedge's g, if a study used 
multiple pain inductions we used the averaged pain score, or if this was not available, we 
used scores for heat/cold or electrical modalities, as these were the most commonly 
reported (as the choice of these modalities might have some influence on the overall effect 
size, we also computed effect sizes for each stimulus modality separately in subgroup 
analysis). If a study reported data from participants before and after anti-depressant 
medication we included only unmedicated data for overall analyses.  Analysis of pain ratings 
was performed only for studies where stimulation intensity was equivalent for both groups 
(i.e. equal time/temperature), to avoid confounding of differences in pain ratings with 
differences in stimulus intensity. Analysis was conducted as described below. 
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First, we compared pain scores in depressed vs. control groups for each primary outcome of 
(1) pain threshold, (2) pain tolerance and (3) pain ratings and for the secondary outcome of 
sensory threshold. Heterogeneity was examined with Cochran's Q and I
2
 statistics to assess 
inconsistency of effect sizes across all studies for each pain outcome
28
.  Cochran's Q tests the 
assumption that all studies share a common effect size, with p<.05 used here to indicate a 
difference in true effect size across compared studies. I
2
 provides an estimate of the 
proportion of the total variation in effect sizes across studies that can be attributed to 
genuine heterogeneity in effect size. Higgins et al.
28
 suggest guidelines of 25%, 50% and 75% 
can be used as rough approximations for low, medium and high heterogeneity. Publication 
bias was assessed with a visual inspection of funnel plots and with the Begg-Mazumdar 
Kendall's tau
8
 and Egger’s bias test
20
.  If we encountered publication bias, we calculated the 
trim and fill adjusted analysis
17
 to remove the most extreme small studies from the positive 
side of the funnel plot, and recalculated the effect size at each iteration, until the funnel plot 
was symmetric around the new effect size.   
Second, we conducted subgroup analysis for pain threshold and tolerance (limited data 
prohibited subgroup analysis of other outcomes). As a primary interest was to determine 
whether depressed vs. control group differences were influenced by stimulus modality, we 
conducted separate analyses for each modality. We used Cochran's Q to test for overall 
differences in effect size across modalities, and if significant, used follow-up Z-tests to 
compare each individual modality vs. every other modality
11
. We also performed separate 
analysis for medicated/unmedicated subgroups, and examined whether results were similar 
when restricting the sample to patients with major depressive disorder (MDD) only.  
Third, we performed meta-regression analysis to examine whether group differences were 
influenced by mean study age, gender composition and magnitude of depressive symptoms 
in the depressed group. Generally, meta-regression was performed only when at least 10 
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studies were available for analysis
29
, although mean age for pain tolerance was also included 
as the 9 studies available closely approximated this guideline.  Pseudo-R
2
, an index of the 
amount of estimated true heterogeneity in effect size that can be accounted for by the 
covariates was also computed. Separate meta-regression analyses were performed for each 
moderator variable. 
Finally, for studies that assessed pain perception before and after antidepressant treatment, 
we pooled within-subject changes in each pain outcome measure using pre and post means 
and SDs for both groups in order to assess the effect of antidepressant treatment on pain 
measurements.   
 
RESULTS 
Study characteristics 
Initial searches yielded 5095 unique hits including 4 records identified through manual 
searching of reference lists. After screening, 65 articles were retained for full text review of 
which 33 were excluded (see Figure 1). Altogether, 32 studies were retained for analysis 
(Table 1). 
Figure 1 here 
 
Table 1 here 
 
Across the 32 retained studies there were 30 unique studies with an aggregated total of 
1317 participants (depression n=641, control n=676). The two non-unique studies
48,62
 were 
linked to two companion papers
56,63
 that used the same sample but provided different 
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outcome data.  Twenty-five studies matched depressed and control samples for age/gender 
or reported no differences, 2 studies reported age/gender differences and 3 studies did not 
report comparisons. The mean age of the depressed samples was 39.3 years (24.5-59.7 
years) and the mean gender composition was 74.0% female (26-100%). The mean illness 
duration, reported in 6 studies, was 8.7 years (2-19 years). For controls, the mean sample 
age was 38.0 years (23.9-53.7 years), with a mean gender composition of 71.4% female.  
Overall, 8 studies were conducted in North-America, 19 in Europe and 2 in South-America, 
with 1 study not specifying region. Studies most commonly used MDD only (k=21 studies), as 
the depressed group, followed by other diagnosed depressive disorders, e.g. persistent 
depressive disorder (k=5), and depressive syndrome based on depression severity assessed 
with a screening questionnaire, e.g. the Beck Depression Inventory (BDI)
7
 (k=4). Depressive 
symptoms were measured in 24 studies, with the most commonly used measure the 
Hamilton Depression Rating Scale (HAMD)
26
 (k=13), followed by the BDI (k=10). 
Antidepressant treatment status was reported as either unmedicated (k=16), fully 
medicated (k =6) or mixed medicated/unmedicated (k=7), with two studies providing data 
on the same sample before and after antidepressant treatment
4,5
. Three studies did not 
report medication status. A study average of 31.4% (range 0-100) of depressed patients 
were treated with antidepressants at baseline (19 studies provided this information). The 
following pain induction methods were used: heat (k=17), cold (k =7), electrical (k =8), 
ischemia by tourniquet procedure (k =6), pressure (k =4), laser (k =1).  
Mean total NOS score across studies was 5.1 with a range of 4-6 (Table 1). Individual quality 
criteria least frequently addressed included participant selection and experimenter blinding. 
More specifically, several studies employed hospital controls and many studies provided 
inadequate descriptions of recruitment procedures for depressed participants and/or 
controls, introducing the potential for selection bias or non-representativeness. In addition, 
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most studies did not report use of experimenter blinding, inviting the possibility of bias in 
the  assessment of pain, although the influence of this might be expected to be minimal 
given the type of pain assessments used. Intra-class correlations and Cohen's Kappa 
indicated adequate inter-rater agreement for total NOS scores, ICC(A, 2)=0.51, and 
excellent
36
 agreement on coding decisions for categorical (Kappa = 0.87-1.00) and 
continuous (ICCs= 0.89-1.00) data, except for extracted SDs (ICC=0.05-0.07). The latter was 
due to two articles misreporting SEMs as SDs and was resolved by further statistical 
investigation, with 100% agreement on all decisions reached after consultation with the 
third rater (CC). 
 
Meta-analysis results 
Details of all meta-analysis results are presented in Table 2, with key findings for each 
outcome measure summarized below. 
1. Pain threshold 
In the pooled analysis, 25 studies including 567 people with depression and 587 controls 
demonstrated a higher overall pain threshold (i.e., reduced pain) in people with depression 
compared to controls, g=0.32, 95%CI [0.05, 0.59], p=0.02. There was no evidence of 
publication bias (Egger=1.0, p=0.68; Begg=0.15, p=0.69). However, statistically significant 
(Q=117, p<.01) and high (I
2
=77%) heterogeneity was observed, with effect sizes varying 
across studies in both magnitude and direction (Figure 2). Given this  variation, subgroup 
analyses were conducted to identify possible moderating variables. 
 
Figure 2 here 
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Subgroup analysis of pain threshold 
Individuals with depression exhibited reduced pain threshold (i.e., increased pain) in all 5 
studies that employed ischemic pain induction (g=-0.81, 95%CI [-1.39, -0.24], p=.006), 
reversing the pattern of results seen for other pain induction methods (Table 2). Cochran's Q 
revealed a significant overall difference in effect size across modalities (Q=10.2, p=.017), 
with Z-tests showing effect size to be significantly different for ischemic compared to other 
modalities (z's=5.25-6.98, p<.0001), with no other significant differences between other 
modalities.  
When MDD-only studies (k=17) were examined, significantly greater pain threshold was 
observed for depressed participants relative to controls (g=0.38, 95%CI [0.02, 0.75], p=0.03). 
The same was true for unmedicated (g=0.32, 95%CI [0.01, 0.70], p=0.04, k=15), but not in 
medicated individuals (g=0.16, 95%CI [-0.55, 0.89], p=0.63, k=5).  
Although subgroup analyses indicate that effect sizes may be influenced by stimulus 
modality, estimates of I
2
 (Table 2) did not noticeably diminish (with the possible exception of 
the cold stimulus), suggesting that considerable heterogeneity remains even when stimulus 
modality is accounted for. 
Meta-regression of pain threshold 
In meta-regression analysis, depressive symptom severity (analyzing only studies that used 
the HAM-D, which was most commonly employed rating scale, in order to increase 
homogeneity of the findings), sex, age or study quality (NOS scores) were not significantly 
related to group differences in pain threshold (k=12-25 studies, β=.00-.24, p=0.14-0.99); see 
Table S2 for full results. Meta-regression was not performed on duration of illness as only 6 
pain threshold studies provided this data. 
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2. Pain tolerance 
Pooling data across 10 studies from 199 people with depression and 215 controls, no overall 
difference in pain tolerance was observed, g=0.09, 95% CI [-0.39, 0.57], p=0.71 (figure S1).  
There was no evidence of publication bias (Begg=-0.26, p=0.28, Egger=-4.1, p=0.16).  Similar 
to pain threshold, a high level of heterogeneity was observed (I
2
=71%), so subgroup analyses 
were conducted. 
Subgroup analysis of pain tolerance 
Depressed participants exhibited significantly reduced pain tolerance (i.e., increased pain) in 
response to ischemic pain induction (g=-0.76, 95% CI [-1.04, -0.47], p<0.001, k=6), but 
without significant differences observed for other pain modalities (Table 2).  Cochran's Q 
showed a significant difference in effect sizes across modalities overall (Q=12.64, p<.01). Z-
tests found effect sizes to be significantly different for ischemic vs. other modalities 
(z's=4.39-6.24, p<.0001), with no other paired comparison being statistically significant.  As 
with pain threshold, although significant differences in effect sizes across modalities were 
observed, heterogeneity was not notably diminished when subgroups were examined 
separately, with the exception of ischemic pain (I
2
=0). 
The lack of overall group differences in pain tolerance in the pooled sample was confirmed 
in the subgroup of unmedicated participants, g=0.02, 95% CI [-0.54, 0.56], p=0.97], k=7, 
(only two studies of tolerance with medicated participants were available, so these were not 
examined). When studies with major depressive disorder only samples were analyzed, 
depressed participants showed higher tolerance than controls, but this finding did not reach 
significance (g=0.41, 95% CI [-0.18, 0.99], p=0.18, k=4).   
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Meta-regression of moderators of pain tolerance 
Although no overall group differences in pain tolerance were found in the previously 
reported meta-analysis, meta-regression was conducted to examine whether group 
differences might be influenced by age, gender or study quality. However, differences 
between depressed and control groups were not significantly moderated by any of these 
variables (Table S2). 
 
3. Pain ratings  
Pooling data from 155 people with depression and 193 controls across 8 studies yielded no 
significant between-group differences in ratings of pain intensity (g=0.00, 95% CI [-0.37, 
0.37], p=0.97). Similarly, pooling data from 4 studies, including 99 people with depression 
and 118 controls, demonstrated no significant group differences in pain affect (g=-0.37, 95% 
CI [-1.29, 0.55], p=0.43).   
 
 
4. Sensory threshold 
Pooling data from 9 studies, including 178 people with depression and 178 controls, sensory 
threshold was significantly higher in people with depression, g=0.35, 95% CI [0.08, 0.62], 
p=0.01 (Figure S2).  There was some evidence of publication bias (Egger=4.7, p=0.05), but 
the effect size remained unchanged when we calculated Duval and Tweedie trim and fill 
method (0.35, 95% CI [0.08, 0.62]). 
  
 Table 2  
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Changes in pain response before and after medication 
Two studies
4,5
 investigated differences in pain threshold, tolerance and sensory threshold 
using heat induction among a total of 42 people with MDD before and after antidepressant 
medication and 42 matched controls at equivalent before/after time points.  Following 
antidepressant medication, the difference in pain threshold between depressed and control 
participants was significantly reduced (g=-0.57, 95% CI [-1.01, -0.12], p=0.01) as was sensory 
threshold (g=-0.44, 95% CI [-0.88, -0.01], p=0.04). No significant effects were observed for 
pain tolerance (g=0.25, 95% CI [-0.18, 0.69], p=0.20) after antidepressant medication.  
Discussion 
The current review is the largest and most comprehensive meta-analysis investigating 
responses to experimentally-induced pain in people with depression vs. healthy controls. 
Several key findings emerged from the study: (1) Pooled mean pain threshold (g=0.32) and 
sensory threshold (g=0.35) were higher in people with depression (indicating diminished 
pain) although considerable study heterogeneity suggested little evidence of a generalized, 
uniform effect of depression; (2) Overall pain tolerance and pain ratings did not differ 
between depressed individuals and controls; and (3) The direction of the relationship 
between depression and pain appeared to be influenced by stimulus modality, with 
depressed individuals showing increased pain for ischemic stimulation, a reversal of the 
pattern found for other modalities. 
Our findings of elevated overall pain threshold in depression confirm and extend preliminary 
findings from a previous meta-analysis of 6 experimental studies
16
, but in a much larger pool 
of 25 pain threshold studies. Small overall effect sizes were observed in both the current 
(g=0.32) and previous meta-analysis (d=0.38). Additionally, we were able to examine a wider 
range of assessment measures than the previous review, including pain tolerance. Although 
there were fewer studies of tolerance available relative to threshold studies, there was little 
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evidence of any link between depression and suprathreshold pain, with no significant 
differences in pain tolerance (g=0.09) found. These findings suggest that depression may be 
associated with a general decreased sensitivity to low intensity stimulation, but not to 
higher intensity stimulation (e.g. that producing tolerance level of pain). The possibility of 
increased thresholds in depression is consistent with attentional pain processing models
19
. 
These state that limited attentional resources are competed for by painful and other, non-
painful stimuli. If greater attention is devoted to non-painful stimuli (e.g. environmental 
stimuli/internal thoughts), as has been observed in depression
45
, this should reduce pain by 
denying it attentional resources; especially for mild pain, which is of relatively low 
attentional priority. Dickens et al.
16
 pointed out that these models would explain the 
increased pain threshold they found in depressed participants, but should also predict little 
difference for higher intensity pain which commands greater attention. While the authors 
were unable to test this hypothesis due to lack of tolerance data, this hypothesis appears to 
be confirmed by our results which offer further support for current attentional models. 
An important caveat in interpreting the association between depression and pain threshold 
is that considerable heterogeneity was observed. Studies varied both in the magnitude and 
direction of effects, suggesting that conclusions regarding a generalized effect of depression 
on pain perception are overly simplistic, and that any such effect may depend upon complex 
constellations of other moderating factors. Based on the current findings, diminished pain 
perception cannot be considered a reliable marker of depression. 
 A key finding was that the depression-pain link appears to be strongly influenced by the 
type of pain induced. Whereas depression was associated with reduced or no alteration of 
pain for most modalities (e.g., heat, cold, electrical), depressed participants exhibited 
increased pain in response to ischemic induction. These differences in responses across 
modalities are consistent with the wider pain literature exhibiting typically weak 
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relationships of pain across different induction methods
49
. The relationship between other 
psychological variables, such as anxiety sensitivity, with pain have also been shown to vary 
across modality
70
. The fact that experimental studies frequently indicate decreased pain in 
depression contrasts with clinical studies, where depressed patients often report more pain 
complaints
2,15
 with increased depression associated with increased pain severity
35
. Given 
that experimental and clinical pain differ on several key dimensions
43
 and are often weakly 
associated
12
, it may be that experimental findings simply do not generalize outside of the 
laboratory. However, the fact that depression is associated with increased pain for ischemic 
(and clinical) pain but with decreased/unaltered pain for other inductions, could contribute 
to our understanding of the discrepancy between experimental and clinical findings. First, 
experimental studies typically rely on exteroceptive stimulation of the skin
44
 (the cold 
pressor also provides stimulation of both deeper and peripheral structures, although 
stimulation of deeper structures is far less pronounced, and several studies examined here 
used a skin contact thermode to induce cold). Both ischemia and clinical pain, however, are 
evoked through interoceptive pathways by nociceptors innervating deep structures
57
 (e.g. 
muscle, joints), involve greater C-fiber recruitment and are subject to greater modulation 
from descending pain inhibitory pathways
57
. Second, pain is a multidimensional experience 
involving sensory, cognitive and affective components
43
, and it may be that depressed 
individuals react more negatively to pain with a stronger affective component. Clinical pain 
is more distressing than typical experimental pain, and ischemic pain is often more severe, 
diffuse and uncontrollable than noxious skin stimulation
43
, so may produce greater negative 
affect (although too few studies recorded pain affect to evaluate this statistically). While the 
suggestion that the depression-pain link may be influenced by pain affect or its 
interoceptive/exteroceptive origin is necessarily speculative, it represents a plausible 
explanation for the discrepancies in findings across different modalities and clinical reports 
that warrant further empirical investigation. 
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If any effects of depression are influenced by modality, pinpointing possible underlying 
mechanisms is largely speculative, given a lack of appropriate empirical data. One possible 
explanation is provided by Lautenbacher and Krieg's global theory of pain processing in 
psychiatric disorders
37
, and speculates that neurotransmitter dysfunction in depression 
affects pain perception in two ways. First, by diminishing spinal and subcortical processing 
which reduces processing of all sensory input therefore elevating sensory/pain thresholds. 
Second, by disrupting descending pain pathways which inhibit sustained or endogenous 
(e.g., ischemic) pain, thus heightening pain of endogenous origin. However, while there is 
some evidence that the areas of the brain involved in mood regulation also regulate pain 
pathways
77
, more empirical data are needed to convincingly demonstrate that depression 
selectively modulates pain processing in this way. 
There is also tentative evidence to suggest that any putative effect of depression on pain 
could be influenced by anti-depressant medication. The two prospective studies found that 
the greater sensory and pain thresholds exhibited by depressed patients relative to controls 
were diminished following antidepressant treatment. In addition, the increased pain 
threshold observed in depressed participants was significant only in the unmedicated and 
not in the anti-depressant medicated group. However, given the minimal difference in effect 
size and the greater power of the unmedicated analysis from more available studies, this 
finding must be considered entirely preliminary. Nevertheless, since several 
neurotransmitters believed to be involved in the pathophysiology of depression are also 
involved in pain, e.g. serotonin, noradrenalin
2
, it would perhaps be unsurprising that 
modulation of these neurotransmitters might restore not only mood but also sensory/pain 
threshold gating. Further data is, however, clearly needed to support any potential effect of 
anti-depressant medication. 
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Several limitations of the current review should be noted. First, considerable study 
heterogeneity was observed which could not be resolved by study differences in symptom 
severity, gender, age or study quality. Given this heterogeneity, caution in interpreting 
findings must be applied, especially where confidence intervals are relatively broad. 
Additionally, although significant differences in effect size across stimulus modalities were 
observed, there is little evidence that modality offers any substantive resolution of this 
heterogeneity. It seems likely that important moderators of the relationship between 
depression and pain perception exist (e.g., methodological, use/non-use of chronic pain 
patients) but remain unidentified. Second, while factors such as the endogenous nature of 
ischemic pain represent one theoretically plausible reason for differences across ischemic 
and other stimuli, other confounding characteristics (e.g. stimulus duration) may offer 
alternative explanations for these differences. Third, fewer studies investigating pain 
tolerance (k=10) were available for analysis compared to pain threshold (k =25). The lack of 
significant overall tolerance differences is unlikely to be attributable to reduced power, 
however, as the aggregated tolerance sample was still large (N=375) and the effect size close 
to zero. Finally, only experimental pain studies were examined and therefore the current 
findings may have limited generalizability to clinical pain. 
Further research should be conducted to help elucidate reasons for inconsistency across 
study findings and identify potential moderators, such as pain duration
54
 and negative pain 
affect
30
, which have been suggested to influence the relationship between depression and 
chronic pain. In addition, measurement and/or careful control of variables likely to differ 
across ischemic and other pain inductions (e.g., stimulus contact time and negative affect), 
could help explain why differences across modalities were observed. Additional studies 
employing within-group designs, where individual variability can be controlled, could directly 
compare ischemic and cutaneous pain inductions to provide further supporting evidence for 
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the role of modality. Future studies should also attempt to improve study quality by striving 
to acquire representative samples for depressed and control participants (e.g. avoiding 
hospital controls) and providing clearer descriptions of recruitment procedures. 
In summary, this is the largest and most comprehensive meta-analysis of experimental pain 
induction studies in individuals with depression to date and suggests two key findings. First, 
there is some evidence that depression may be associated with an overall reduced 
perceptual sensitivity to low, but not high intensity stimulation. However, this overall effect 
is relatively small and considerable variation in study findings indicates that diminished pain 
may only be evident under certain, partly unidentified conditions. Second, any putative 
impact of depression appears to be strongly influenced by modality, with depressed 
participants showing increased pain in response to ischemic stimulation, but reduced or 
unaltered pain perception in response to other stimulus modalities. This finding is consistent 
with theory proposing different neural pathways for interoceptive and cutaneous-based 
pain and suggests that depression could affect these pathways differentially. Overall, these 
findings provide support for a relationship between depression and pain, but indicate that 
this relationship is complex and deserves further research that pays particular attention to 
variability due to stimulus intensity and modality as well as additional moderating variables. 
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Figure 1. Prisma flow diagram 
Figure 2. Pain threshold in depressed vs. control participants 
Figure S1. Pain tolerance in depressed vs. control participants 
Figure S2. Sensory threshold in depressed vs. control participants 
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Table 1. Summary of included studies 
Author Location & 
Setting 
Depression group Antidepressant 
Treatment 
Control 
participants 
Pain 
modality 
Pain measure  NOS 
scores 
Zambito 
Marsala et al 
2015
76
  
Italy, setting 
not stated 
N=27, MDD, 26% female, 
age=47.2 years, HAM-D: 22.6. 
Pain screening
c
=yes 
Unmedicated N=27, 26% 
female, age=53.7 
Electrical Sensory threshold 
Pain threshold 
Pain tolerance 
5 
Rodriguez-
Raecke et al 
2014
a,56
 
Germany, 
inpatient 
N=21, MDD, 38% female, 
age=36.1 years. Pain screening 
=yes 
Mixed N=21, 71% 
female, age=36.8 
Heat Pain threshold 
fMRI 
6 
Muhtz et al 
2013
a,48
 
Germany, 
inpatient 
N=22, MDD, 27% female, 
age=36.3 years. Pain screening 
=yes 
Mixed  N=33, 64% 
female, age=33.3 
Heat Intensity rating 6 
Bär et al 2011 
5
 Germany, 
setting not 
stated 
N=22, MDD, 77% female, 
age=42.2 years, Baseline 
MADRS: 25.36, BDI: 22.5; 6 
weeks: MADRS: 9.41, BDI: 
11.36.  Participants scoring >3 
on present pain excluded  
Unmedicated/ 
Medicated 
(Duloxetine) 
N=22, 77% 
female, age=42.5 
Heat 
Ischemic 
Sensory threshold 
Pain threshold 
Pain tolerance 
Intensity rating 
6 
Normand et al 
2011
50
 
Canada, 
setting not 
stated 
N=26, MDD, 61% female, 
age=46.5 years. Pain screening 
=yes 
Medicated  N=40, 60% 
female, age=45.2 
Heat 
Cold 
Pain threshold 
Intensity rating 
5 
Terhaar et al 
2011
69
 
Germany, 
inpatient 
N=27, MDD, 78% female, 
age=38.5 years, BDI: 23, HAM-
D: 23.2. Pain screening =yes 
Unmedicated N=27, 78% 
female, age=39.5 
Laser Sensory threshold 
Pain threshold 
5 
Euteneuer et al 
2011
21
 
Germany, 
outpatient 
N=37, MDD, 56.7% female, 
age=33.5 years, BDI: 21.46, SCL 
90-R GSI: 1.03. Pain screening 
=yes 
Mixed N=48, 63% 
female, age=35.8 
Pressure Pain threshold 4 
Strigo et al 
2010
61
 
US, setting 
not stated 
N=15, MDD, 80% female, 
age=24.5 years, BDI-2: 27.8. 
Pain screening =yes 
 
Unmedicated N=17, 59% 
female, age=24.3 
Heat Pain threshold (for 
'moderate' pain) 
5 
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Author Location & 
Setting 
Depression group Antidepressant 
Treatment 
Control 
participants 
Pain 
modality 
Pain measure  NOS 
scores 
Klatzkin et al 
2010
33
 
 
 
US, setting 
not stated 
N=10, PMDD, 100% female, 
age not stated. Pain screening 
=yes 
Unmedicated N=18, 100% 
female, age not 
stated 
Cold pressor 
Ischemic 
Pain threshold 
Pain tolerance 
Intensity rating 
Unpleasantness 
5 
Lopez-Sola et al 
2010
41
 
Spain, setting 
not stated 
N=13, MDD, 85% female, 
age=44.6 years, HAM-D: 21.3, 
Pain screening =yes 
Medicated  N=20, 75% 
female, age=47.2 
Heat Intensity 
Unpleasantness 
fMRI 
5 
Boettger et al 
2010
10
 
Germany, 
inpatient 
N=22, MDD, % female not 
stated, age=41 years, BDI: 
24.2, HAM-D: 23.0. Pain 
screening =not stated 
Mixed N=20, % female 
not stated, 
age=40 
Electrical Intensity rating 
EEG 
5 
Terhaar et al 
2010
68
 
Germany, 
inpatient 
N=25, MDD, 100% female, 
age=49.8 years, BDI: 18.8, 
MADRS: 21.7. Pain ratings>2 
was exclusion criterion 
Mixed N=25, 100% 
female, age=48.3 
Heat Pain threshold 5 
Schwier et al 
2010
58
 
Germany, 
setting not 
stated 
N=20, MDD, 85% female, 
age=37.2 years, HAM-D: 19.4, 
BDI: 24.3. Pain screening =yes 
Unmedicated N=20, 85% 
female, age=34.8 
Cold Pain threshold 5 
Strigo et al 
2008
b,62
 
US, setting 
not stated 
N=15, MDD, 80% female, 
age=24.5 years, BDI: 27.8. Pain 
screening =yes 
Unmedicated N=15, 80% 
female, age=23.9 
Heat Pain threshold 
Intensity rating 
Unpleasantness rating 
6 
Strigo et al 
2008
b,63
 
US, setting 
not stated 
N=15, MDD, 80% female, 
age=24.5 years, BDI: 27.8. Pain 
screening =yes 
Unmedicated N=15, 67% 
female, age=24.3 
Heat fMRI 5 
Klauenberg et al 
2008
34
 
Germany, 
inpatient 
N=25, Mixed diagnosis types, 
60% female, age=48 years, 
HADS (depression): 13, HADS 
(anxiety): 13. Pain screening 
=not stated 
Medicated N=25, 67% 
female, age=47. 
Cold 
Heat 
Mechanical 
(von Frey) 
Mechanical 
(pressure) 
 
Sensory threshold 
Pain threshold 
Intensity rating 
5 
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Pain measure  NOS 
scores 
Bär et al 2007 
6
 Germany, 
inpatient 
N=13, MDD, 100% female, 
age=35.9 years, HAM-D: 23.7, 
BDI: 26.5, STAI-X1: 42.0, STAI-
X2: 46.1. Pain screening: all 
participants pain ratings<2 
Unmedicated N=13, 100% 
female, 
age=34.3. 
Heat Pain threshold 
fMRI 
5 
Bär et al 2005 
3
 Germany, 
setting not 
stated 
N=30, MDD, 77% female, 
age=44.9 years, HAM-D: 21.9. 
Pain screening =yes 
Mixed (mostly 
medicated) 
N=30, 77% 
female, 
age=44.7. 
Heat 
Electrical 
Ischemic 
Pain threshold 
Pain tolerance 
 
5 
Spernal et al 
2003
60
 
Germany, 
inpatient 
N=21, MDD, 57% female, 
age=39 years, HAM-D: 23.6, 
HAM-A: 21.2. Pain screening 
=not stated 
Unmedicated N=20, 60% 
female, age=34.6 
Heat 
Cold pressor 
Pressure 
Pain threshold 
 
5 
Suarez-Roca et 
al 2003
67
 
Venezuela, 
setting not 
stated 
N=11, Dysthymic, 91% female, 
age=32.4 years, Zung’s index: 
60. Pain screening =not stated 
Not stated N=19, 79% 
female, age=31.4 
Ischemic Pain tolerance 
Intensity rating 
5 
Bär et al 2003 
4
 Germany, 
setting not 
stated 
N=20, MDD, 70% female, 
age=40.1 years, BDI: 22.8, 
HAM-D: 28.1 Pain screening 
=not stated 
Unmedicated/ 
Medicated 
N=20, 70% 
female, age=38.8 
Heat Sensory threshold 
Pain threshold 
Pain tolerance 
6 
Lautenbacher et 
al 1999
39
 
Germany, 
inpatient 
N=13, MDD, 62% female, 
age=35.4 years, HAM-D: 23.8, 
HAM-A: 23.2. Pain screening 
=not stated 
Unmedicated 
 
N=13, 62% 
female, age=32.9 
Pressure 
Cold pressor 
Heat 
Pain threshold 
 
5 
Pinerua-
Shuhaibar et al 
1999
52
 
Venezuela, 
setting not 
stated 
N=11, Dysthymic, 91% female, 
age=32 years, Zung: 59. Pain 
screening =not stated 
Unmedicated N=32, 47% 
female, age=32 
Ischemic Pain threshold 
Pain tolerance 
Intensity rating 
Unpleasantness rating 
4 
Marazziti et al 
1998
42
 
Italy, 
Outpatient 
N=13, MDD, 69% female, 
age=43.6 years, HAM-D: 18.3, 
SAD: 71.2. Pain screening =not 
stated 
Mixed (mostly 
unmedicated) 
N=13, 38% 
female, age=30.7 
Electrical Sensory threshold 
Pain tolerance 
4 
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Fillingim et al 
1995
23
 
US, setting 
not stated 
N=7, PDD, 100% female, 
age=35.1 years. Pain screening 
=yes 
Unmedicated N=11, 100% 
female, age=31.4 
Heat 
Ischemic 
Pain threshold 
Pain tolerance 
5 
Dworkin et al 
1995
18
 
US, Inpatient N=26, MDD, 73% female, 
age=42.4 years. Pain screening 
=not stated 
Not stated N=32, 50% 
female, age=46.6 
Heat Pain threshold 5 
Lautenbacher et 
al 1994
38
 
Germany, 
setting not 
stated 
N=20, MDD, 40% female, 
age=36.9 years, HAM-D: 25.1. 
Pain screening =not stated 
Mixed N=20, 40% 
female, age:36.2 
Heat 
Pressure  
Pain threshold 
Sensory threshold 
5 
Adler et al 1993
1
 Germany, 
setting not 
stated 
N=16, MDD, 56% female, 
age=33.2 years, HAM-D: 26.7. 
Pain screening =not stated 
Unmedicated N=16, %female 
not stated, age 
not stated 
Electrical Sensory threshold 
Pain threshold 
 
4 
Otto et al 1989
51
 US, setting 
n/a 
N=16, BDI=>16 (depression), 
100% female, age not stated, 
BDI: 25.9. Pain screening =not 
stated 
Unmedicated N=16, 100% 
female, age not 
stated 
Cold pressor Pain threshold 
Pain tolerance 
Intensity rating 
5 
Ben-Tovin et al 
1981
9
 
Location not 
stated, 
Inpatient 
N=8, Primary affective 
disorder: depressed type, 
100% female, age=59.7 years, 
HAM-D: 18.8. Pain screening 
=not stated 
Medicated N=8, 100% 
female, age=37.2 
Electrical Sensory threshold 
Pain threshold 
 
6 
Davis et al 
1979
14
 
US, inpatient N=66, Depressed (Bunney-
Hamburg rating scale, global 
mania => 2), 61% female, 
age=38 years. Pain screening 
=not stated 
Unmedicated N=48, 65% 
female, age=38.2 
Electrical Pain threshold 
Unpleasantness rating 
EEG 
5 
von Knorring et 
al 1974
72
  
Sweden, 
setting not 
stated 
N=45, Depressive disorders, % 
female not stated, age not 
stated. Pain screening =not 
stated 
 
Not stated N=20, % female 
not stated, age 
not stated 
Electrical Pain threshold 
Pain tolerance 
 
 
5 
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Author Location & 
Setting 
Depression group Antidepressant 
Treatment 
Control 
participants 
Pain 
modality 
Pain measure  NOS 
scores 
TOTAL 
 
Studies=32 
(Unique=30);  
Region: N 
America=8, 
Europe=19, 
S America 2, 
Not stated=1; 
Setting: 
Outpatient=2 
Inpatients=11, 
Unclear=17 
N=641 participants with 
depression, mean age= 39.3 
years, females=74.0%. 17 
studies screened for chronic 
pain, 15 studies did not. 
Antidepressant-
treated=6;  
Unmedicated= 16; 
Mixed = 7; Not 
stated =3 
N=676 controls, 
mean age=38.0  
years, 
females=71.4%  
Heat=17; 
Cold=7; 
Pressure=4; 
Ischemic=6;  
Laser=1; 
Electrical=8; 
Mechanical=1  
Pain threshold=26;  
Pain intensity=11; 
Pain tolerance=11; 
Sensory threshold=9; 
Pain unpleasantness=5; 
fRMI=4; 
EEG=2 
 
 
Key: BDI: Beck Depression Inventory; EEG: Electroencephalography; HAM-A: Hamilton Anxiety Rating Scale; HAM-D: Hamilton Rating Scale for Depression; 
MADRS: Montgomery Asberg Depression Rating Scale; MDD: Major Depressive Disorder; PMDD: Premenstrual Dysphoric Disorder; SAD: Scala di 
Autovalutazione per la Depressione; STAI: State-Trait Anxiety Inventory.   
a,b
Identical superscript symbol indicates same sample used across two studies (but different pain outcomes reported in each) 
c
Screening for chronic pain 
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Table 2. Meta-analysis results of experimental pain in depression versus controls (positive Hedges g indicates reduced pain sensitivity in depression) 
 Number 
of studies 
Number of 
participants 
Meta-analysis Heterogeneity Publication bias 
  Depression Control Hedges 
g 
95% CI P 
value 
Q (p value) 
  
I
2
 Begg Egger 
PAIN THRESHOLD            
 Main analysis 25 567 587 0.32 0.05 0.59 0.02 117,p<0.01 77 0.15, p=0.69 1.0, p=0.68 
 MDD only 17 379 409 0.38 0.02 0.75 0.03 101,p<0.01 83 0.13, p=-0.56 1.4, p=0.54 
 Medication            
  Unmedicated 15 304 318 0.32 0.01 0.70 0.049 54, p<0.01 77 -0.06, p=0.89 0.4, p=0.88 
  Medicated 5 101 115 0.16 -0.55 0.89 0.63 33, p<0.01 89 0.24, p=0.56 0.3, p=0.61 
 Modality            
  Heat 14 284 307 0.35 -0.04 0.74 0.07 72, p<0.01 77 0.31, p=0.71 0.8, p=0.51 
  Cold 6 105 112 0.30 -0.38 0.97 0.38 30, p<0.01 34 0.50, p=0.48 1.0, p=0.46 
  Electrical 6 192 149 0.37 -0.15 0.88 0.16 25, p<0.01 80 -0.20, p=0.57 0.8, p=0.63 
  Ischemia 5 80 113 -0.81 -1.39 -0.24 0.006 13, p<0.01 71 -0.56, p=0.26 -1.0, p=0.23 
PAIN TOLERANCE            
 Main analysis 10 199 215 0.09 -0.39 0.57 0.71 50, p<0.01 72 -0.26, p=0.28 -4.1, p=0.16 
 MDD only 4 99 99 0.41 -0.18 0.99 0.18 9, p=0.03 64 -0.16, p=0.73 -2.4, p=0.68 
 Medication            
  Unmedicated 7 113 146 0.02 -0.54 0.56 0.97 28, p<0.01 77 0, p=1 -1.9, p=0.71 
 Pain Modality            
  Heat 4 79 83 0.51 -0.13 1.15 0.12 11, p=0.01 45 -0.8, p=0.12 -13, p=0.08 
  Cold 2 26 34 0.33 -1.08 1.58 0.79 5, p=0.21 85 N/A N/A 
  Electrical 3 77 77 0.15 -0.75 1.05 0.74 11, p=0.03 83 0, p=1 -5.0, p=0.68 
  Ischemia 
 
6 91 132 -0.76 -1.04 -0.47 <0.001 5, p=0.36 0 0.13, p=0.70 2.6, p=0.38 
PAIN AFFECT  4 99 118 -0.37 -1.29 0.55 0.43 31, p<0.01 90 -0.16, p=0.73 -5.6, p=0.49 
PAIN INTENSITY  8 155 193 0.00 -0.37 0.37 0.97 21, p<0.01 66 -0.3, p=0.90 -3.8, p=0.40 
SENSORY THRESHOLD 9 178 178 0.35 0.08 0.62 0.01 12, p=0.12 36 0.66, p=0.11 4.7, p=0.05 
Key: MDD= major depressive disorder, N/A= not applicable (<3 studies publication bias not applicable). 
Bolded values: significant effect size results 
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Figure 1. PRISMA flow diagram 
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 Additional records identified 
through other sources 
(n = 4) 
Records after duplicates removed 
(n =   5095)  
Records screened 
(n =  5095) 
Records excluded 
(n =  5030) 
Full-text articles assessed 
for eligibility 
(n = 65)  
Full-text articles excluded 
(n = 33) 
no baseline pain assessment (N=7) 
no control group (N=6) 
unsuitable depression group (N=5)  
no pain measure (N=6) 
no response to data request (N=5) 
review article (N=2) 
duplicate publication (N=2) 
Studies included in 
qualitative synthesis 
(n = 32) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 32)  
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Highlights 
• Meta-analysis of 32 experimental pain studies compared depressed vs. controls  
• Higher overall pain threshold in depression but strong heterogeneity evident 
• No differences in pain tolerance 
• Depression and pain link may be dependent upon type of pain stimulation 
